Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Genetics Are Key to Lowering Bone Fracture Risk

By LabMedica International staff writers
Posted on 08 May 2017
A study has found that postmenopausal women who are more genetically prone to fractures benefit most from hormone therapy (HT). More...
The results therefore have implications that could advance personalized medicine for postmenopausal women.

“We found that women who are genetically at the highest fracture risk can enjoy the greatest protection from fracture when they use HT,” said Heather Ochs-Balcom, associate professor at University at Buffalo (Buffalo, NY, USA), who led the study team made up of researchers at UB and their collaborators at Ohio State University (USA) and University of California (USA). “This study provides a better understanding of who can benefit the most in terms of bone health from HT use,” she said, “It’s important information as women and their doctors make decisions.”

The study included nearly 10,000 participants from the Women’s Health Initiative (WHI), a national, long-term study begun in 1991 that consisted of a set of clinical trials and an observational study. Combined, they included over 161,000 generally healthy postmenopausal women aged 50-79. As one of 40 WHI centers nationwide, the University at Buffalo serves as the Northeast Regional Center.

The study, considered to be the first to investigate gene-HT interaction on fracture in postmenopausal white women, utilizes the largest set of known genes linked to fracture risk from a meta-analysis of genome-wide association studies. The researchers looked at a subset of 9,922 women from among the more than 27,000 that had participated in WHI hormone therapy clinical trials. They wondered whether women who are more genetically susceptible to fractures could benefit from hormone therapy.

“Our study represents a first look at how inherited predisposition to fracture is related to HT use,” said Prof Ochs-Balcom. “This is important because, as previous WHI studies have identified, there are risks and benefits with HT,” she noted, “This is where precision or personalized medicine comes in – the attempt to get the right drugs to the right person to ensure the most benefit and least harm.”

First author Youjin Wang, who conducted the research as a UB doctoral candidate, added, “further studies on gene-therapy interaction are warranted to evaluate the advantages of targeted interventions based on genetic profile.” The research team is currently analyzing other gene-environment interactions and recently published another study on the association of calcium plus vitamin D supplementation and genetic risk of fracture.

The study, by Wang Y et al, was published March 6, 2017, in the Journal of Clinical Endocrinology and Metabolism.


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.